Betamethasone in plus phenobarbitone prior to hepatobiliary scintigraphy increases diagnostic accuracy in infants with jaundice

被引：17

作者：

Gupta D.K. ^{[1
]}

Charles A.R. ^{[1
]}

Srinivas M. ^{[1
]}

Dave S. ^{[1
]}

Bal C.S. ^{[2
]}

机构：

[1] Department of Pediatric Surgery, All India Inst. of Medical Sciences, New Delhi

[2] Department of Nuclear Medicine, All India Inst. of Medical Sciences, New Delhi

来源：

The Indian Journal of Pediatrics | 2001年 / 68卷 / 11期

关键词：

Extrahepatic biliary atresia; Hepatobiliary scintigraphy; Neonatal hepatitis;

D O I：

10.1007/BF02722353

中图分类号：

学科分类号：

摘要：

Objective. In the diagnostic work up of the child with neonatal obstructive cholangiopathy (NOC), hepatobiliary scintigraphy (HBS) determines the need for peroperative cholangiography (POC). Traditionally, phenobarbitone is recommended to prime the liver to HBS. This retrospective study was designed to evaluate whether addition of the betamethasone (BM) alters the diagnostic accuracy of the HBS in distinguishing neonatal hepatitis (NH) from extra hepatic biliary atresia (EHBA). Methods. Between 1993 - 1999, 202 patients presented with NOC and this study was not designed as a prospective randomized clinical trial. Of these, 126 patients had received Phenobarbitone (Group I) and the remaining 76 (Group II) had received BM in addition to the PB in a dose of 5 mg/k/d and 2.2 mg/k/d respectively for 7 days prior to HBS. Results. Retrospective analysis revealed that, in the Group I, 41 showed excretion and 85 did not show any excretion of the radiopharmaceutical and the latter underwent POC which revealed that 31 patients (36%) of them showed patent biliary tract. In group II, 32 patients revealed excretion and 44 did not show any excretion of the radiopharmaceutical and the latter had undergone POC, which revealed that only 8 patients (18%) showed patent biliary tract. The percentages of false positives (36% vs 18%) was statistically significant (p<0.03). Conclusion. Addition of BM increases the diagnostic accuracy of the HBS and this would lead to decreased need for POC to distinguish NH from EHBA.

引用

页码：1039 / 1041

页数：2

共 19 条

[1]

Kirks D.R., Coleman R.E., Filston H.C., Rosenberg E.R., Merten D.F., An imaging approach to persistent neonatal jaundice, AJR Am J Roentgenol, 142, pp. 461-465, (1984)

[2]

Kasai M., Results of surgery for biliary atresia, Neonatal Hepatitis and Biliary Atresia, pp. 417-430, (1979)

[3]

Hitch D.C., Leonard J.C., Pysher T.J., Manion C.V., Smith E.I., Differentiation of cholestatic jaundice in infants. Utility of diethyl-IDA, Am J Surg, 142, pp. 671-677, (1981)

[4]

Majd M., Reba R.C., Altman R.P., Hepatobiliary scintigraphy with 99mTc-PIPIDA in the evaluation of neonatal jaundice, Pediatrics, 67, pp. 140-145, (1981)

[5]

Majd M., Reba R.C., Altman R.P., Effect of phenobarbital on 99mTc-IDA scintigraphy in the evaluation of neonatal jaundice, Semin Nucl Med, 11, pp. 194-204, (1981)

[6]

Macarol V., Morris T.Q., Baker K.J., Bradley S.E., Hydrocortisone choleresis in the dog, J Clin Invest, 49, pp. 1714-1723, (1970)

[7]

Miner P.B. Jr., Gaito J.M., Bile flow in response to pharmacologic agents. Hepatic DNA as a reference standard, Biochem Pharmacol, 1-28, 7, pp. 1063-1066, (1979)

[8]

Muraji T., Higashimoto Y., The improved outlook for biliary atresia with corticosteroid therapy, J Pediatr Surg, 32, pp. 1103-1106, (1997)

[9]

Karrer F.M., Lilly J.R., Corticosteroid therapy in biliary atresia, J Pediatr Surg, 20, pp. 693-695, (1985)

[10]

Manolaki A.G., Larcher V.F., Mowat A.P., Barrett J.J., Portmann B., Howard E.R., The prelaparotomy diagnosis of extrahepatic biliary atresia, Arch Dis Child, 58, pp. 591-594, (1983)

← 1 2 →